We are live on ! Find out more
GMO

General Moly, Inc.
GMO

Delisted

GMO was delisted on the 30th of September, 2020.

39 hedge funds and large institutions have $3.31M invested in General Moly, Inc. in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

4% more capital invested

Capital invested by funds: $3.18M → $3.31M (+$127K)

0% more funds holding

Funds holding: 3939 (0)

Holders
39
Holders Change
Holders Change %
0%
% of All Funds
0.97%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
8
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UOTTAIMCU
1
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$1.1M
Vanguard Group
2
Vanguard Group
Pennsylvania
$810K +$950 +2,248 +0.1%
BlackRock
3
BlackRock
New York
$589K +$1.85K +4,389 +0.3%
Bank of America
4
Bank of America
North Carolina
$121K
Geode Capital Management
5
Geode Capital Management
Massachusetts
$98K
Renaissance Technologies
6
Renaissance Technologies
New York
$87K +$45.2K +107,014 +85%
Deutsche Bank
7
Deutsche Bank
Germany
$75K +$40K +94,632 +88%
SIM
8
Sonora Investment Management
Arizona
$61.1K
EA
9
Evanston Advisors
Illinois
$56K
California Public Employees Retirement System
10
California Public Employees Retirement System
California
$53K
Northern Trust
11
Northern Trust
Illinois
$45K
Bank of New York Mellon
12
Bank of New York Mellon
New York
$31K
VF
13
Virtu Financial
New York
$24K +$27.1K +64,160 New
MBA
14
McQueen Ball & Associates
Pennsylvania
$21K
State Street
15
State Street
Massachusetts
$18K
UBS Group
16
UBS Group
Switzerland
$16K +$16.4K +38,862 +2,591%
UCFA
17
United Capital Financial Advisors
Texas
$15K
Goldman Sachs
18
Goldman Sachs
New York
$11K -$25.7K -60,905 -67%
Citadel Advisors
19
Citadel Advisors
Florida
$11K -$1.11K -2,617 -8%
LTFS
20
Ladenburg Thalmann Financial Services
Florida
$9K +$1.23K +2,900 +15%
CAN
21
Cetera Advisor Networks
California
$8K
KAM
22
Kazazian Asset Management
Florida
$8K
GC
23
Guggenheim Capital
Illinois
$8K +$1.75K +4,151 +23%
HIIFS
24
Harel Insurance Investments & Financial Services
Israel
$7K
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$7K +$8.11K +19,186 New

GMO Hedge Fund Activity: Q3 2017 in Review

39 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in General Moly, Inc. (GMO) for Q3 2017, worth a combined $3.31M — up 4% from $3.18M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new GMO positions and 3 closed out — a net gain of 2 holders — while 8 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $45.2K. The largest seller was Goldman Sachs, cutting an estimated $25.7K.

  • 39 institutional investors held General Moly, Inc. (GMO) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $3.31M of General Moly, Inc. stock for Q3 2017, up 4% quarter-over-quarter.
  • 5 funds opened new General Moly, Inc. positions in Q3 2017 and 3 closed out, a net change of +2 holders.
  • The largest General Moly, Inc. buyer in Q3 2017 was Renaissance Technologies, an estimated $45.2K added.
  • The largest General Moly, Inc. seller in Q3 2017 was Goldman Sachs, an estimated $25.7K sold.

Based on aggregated 13F filings for Q3 2017.